(1 - 21 from 23
)
9th Annual Neurodegenerative Drug Development Summit - Alzheonalzheon.com › Events
alzheon.com
Martin Tolar, Founder, President & CEO, Alzheon; Isaac Veinbergs, President & CEO, Libra The…utics; Peter Lansbury, Chief Scientific Officer, BIAL ...
Libra The…utics Launches With Pipeline of 3 ALS Treatment ...alsnewstoday.com › news-posts › › libra-the…utics-launches...
Oct 9, · ... disease have on patients and their families,” Isaac Veinbergs, PhD, president and CEO of Libra The…utics, said in a press release.
Libra The…utics Launches with $29 Million Sante Venturessante.com › newsroom › libra-the…utics-launches-with-29-million-series...
Sep 24, · Company appoints Isaac Veinbergs, Ph.D., an established leader with strong expertise in diseases of the central nervous system, as CEO.
Libra The…utics Launches with $29M Series A - VC News Dailyvcnewsdaily.com › venture-capital-funding › wcnwzpgpkv
Sep 23, · ... and Parkinson's disease have on patients and their families," said Isaac Veinbergs, Ph.D., President and CEO of Libra The…utics.
sorted by relevance / date